 |
Cytomegalovirus immune globulin (human) |
|---|---|
| Trade Name | Cytogam |
| Orphan Indication | Prevention or attenuation of primary cytomegalovirus disease in immunosuppressed recipients of organ transplants |
| USA Market Approval | USA |
| USA Designation Date | 1987-08-03 00:00:00 |
| Sponsor | CSL Behring LLC;1020 First Avenue, P. O. Box 61501;King of Prussia, Pennsylvania, 19406 |
